A global example in the fight against COVID-19 and for the future of our specialty

19 October, 2020
20 October, 2020

Views 52Views

License

This is an open-access article distributed by the terms of the Creative Common Attribution License (CC-BY NC-4). The use, distribution or reproduction in other forms is permitted, provided the original author(a) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with this terms.

A global example in the fight against COVID-19 and for the future of our specialty

Introduction

The rheumatological community has done an excellent job and we have learned a lot from the virus and its effects on all  spheres of  society. However, this is only the beginning of a long pathway to unfold the countless mysteries of a virus that is here to stay.

 

 

References

 

  1. Calabrese LH, Calabrese C., Reflections on rheumatological aspects of COVID-19. Curr Opin Rheumatol. 2020;32(5):427-428. doi: 10.1097/BOR.0000000000000733
  1. Wallace ZS, Bhana S, Hausmann JS, Robinson PC, Sufka P, Sirotich E, Yazdany J, Grainger R. The Rheumatology Community responds to the COVID-19 pandemic: the establishment of the COVID-19 global rheumatology alliance. Rheumatology (Oxford). 2020 Jun 1;59(6):1204-1206. doi: 10.1093/rheumatology/keaa191
  1. Robinson, PC, Yazdany, J. The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic. Nat Rev Rheumatol; doi: https://doi.org/10.1038/s41584-020-0418-0.
  1. Hausmann JS, Sufka P, Bhana S, Liew JW, Machado PM, Wallace ZS, et al. Conducting research in a pandemic: The power of social media. Eur J Rheumatol 2020; 10.5152/eurjrheum.2020.2066
  1. Benucci M, Damiani A, Infantino M, Manfredi M, Quartuccio L. Old and new antirheumatic drugs for the treatment of COVID-19.Joint Bone Spine. 2020 May;87(3):195-197. doi: 10.1016/j.jbspin.2020.03.013.
  1. Shamdasani P, Trubiano JA, Smibert OC, Owen CE, Liew DFL. COVID-19: collaboration will keep us ahead of the curve. Intern Med J. 2020 Jul;50(7):784-786. doi: 10.1111/imj.14888.
  1. Gianfrancesco M, Hyrich KL, Al-Adely S, et al. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis. 2020;79(7):859-866.
  1. Brenner EJ, Ungaro RC, Gearry RB, Kaplan GG, Kissous-Hunt M, et al. Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry. Gastroenterology. 2020 ;159(2):481-491.e3. doi: 10.1053/j.gastro.2020.05.032.
  1. World Health Organization. WHO coronavirus disease (COVID-19) dashboard. [cited 2020 October 3]. Available from: https://covid19.who.int 
  2. Ugarte-Gil M, et al. Característics associated with Covid-19 in patients with Rheumatic Disease in Latin America: data from the Covid-19 Global Rheumatology Alliance physician-reported registry. Global Rheumatology by Panlar 2020; disponible en https://globalrheumpanlar.org/node/254
  3. Hodkinson B, Singh P, Gcelu A, Molano WB, Pons-Estel G, Alpízar-Rodríguez D.Navigating COVID-19 in the developing world.Clin Rheumatol. 2020 Jul;39(7):2039-2042. doi: 10.1007/s10067-020-05159-4.
  4. Elena-Fitzcarrald C, Ugarte-Gil MF, Alarcón GS.COVID-19 and Its Potential Effect on Patients With Rheumatic Diseases in Latin America.J Clin Rheumatol. 2020;26(6):215-217. doi: 10.1097/RHU.0000000000001493.
  5. Fajardo E. Covid 19, una pandemia acompañada de Infodemia. Global Rheumatology by Panlar 2020; disponible en https://globalrheumpanlar.org/articulo/covid-19-una-pandemia-acompanada-de-infodemia-223
  6. Solomon DH, Bucala R, Kaplan MJ, Nigrovic PA.Arthritis Rheumatol. 2020; 2:10.1002/art.41468. doi: 10.1002/art.41468.
  1. Yazdany J. COVID-19 in Rheumatic Diseases: A Research Agenda..Arthritis Rheumatol. 2020; 23:10.1002/art.41447. doi: 10.1002/art.41447.
  1. Felten R, Chatelus E, Arnaud L.How and why are rheumatologists relevant to COVID-19? Joint Bone Spine 2020;87(4):279-280. doi: 10.1016/j.jbspin.2020.04.006.

 

 

 

 

 

 

 

enviar Envía un artículo